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Acute treatment of headache
T U T O R I A L
Alan M. Rapoport
Abstract Effective acute treatment
of headache begins with making an
accurate diagnosis and ruling out
secondary causes of headache.
Once a primary headache is diag-
nosed, it is important to choose the
right combination of behavioural
therapy and acute care (abortive
and symptomatic) therapy for each
patient. Some patients may need
preventive medication on a daily
basis. If patients overuse acute
medications and develop medica-
tion overuse headache (previously
called analgesic rebound
headache), they often seek medical
attention due to the chronicity
and/or intensity of their pain and
resultant disability. For acute care
of migraine, physicians should
choose a triptan they know and
expect to work. They should pre-
scribe the dose and route of admin-
istration that will provide the most
rapid and complete response to all
the associated symptoms of
migraine, in addition to the pain.
The effectiveness of the 7 available
triptans in early, double-blind, con-
trolled trials is more similar than
different. How and when to give
them will be discussed. Treatment
of cluster headache will be present-
ed briefly.
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Introduction
Effective treatment of headache begins with a proper eval-
uation of the patient to rule out secondary causes of
headache. This is done by taking a careful history, doing a
complete physical and neurological examination, and per-
forming blood tests and scans when appropriate [1]. Then
accurate diagnosis of primary headache disorders and
choice of the right combination of behavioural therapy,
acute care (abortive and symptomatic) therapy and pre-
ventive pharmacotherapy can proceed.
Establishing a close therapeutic partnership with the
patient and then educating them about probable patho-
physiology and the various treatment strategies and trig-
ger avoidance is essential. The physician must be aware of
the specific headache characteristics he/she is treating, the
degree of disability the patient is experiencing and the
patient’s preferences for treatment. It is also important to
know why the patients have come to see you. Some
patients visit the specialist to obtain a diagnosis or to be
certain they do not have a brain tumour, and others want
effective treatment. Some prefer treatments that work
quickly, others treatments that work completely or consis-
tently and still others treatments that do not cause any
adverse effects. Goals should be discussed and therapeu-
tic strategies planned. Expectations should be put in prop-
er perspective.
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Mild headaches are often treated with over-the-counter
(OTC) medication by patients who never come to the doc-
tor. When headaches become more severe and frequent or
if patients overuse these non-specific medications and
develop medication overuse headache (MOH) (previously
called analgesic rebound headache), they often seek med-
ical attention due to the chronicity and/or intensity of their
pain and resultant disability. Doctors sometimes inadver-
tently cause the patient to develop MOH. Some patients
are put on large amounts of prescription NSAIDs, butal-
bital-containing medication (in certain countries like the
USA) and various simple and combination analgesics by
their primary care physicians or nurse practitioners, often
with limited effectiveness, or actual worsening and
adverse effects.
Headache specialists shun step care therapies and
usually opt for stratified care, treating with the correct
medication (usually a triptan) the first time. Although
there are some patients with frequent headaches that can
take acute care analgesics and NSAIDs up to 2
days/week, and triptans for their more severe migraine
attacks, this type of regimen often prevents significant
improvement as the patient medicates too frequently.
Physicians first need to assess and treat for overuse of
analgesics or triptans, and then institute effective triptan
and possibly preventive therapy.
Physicians should choose a triptan they know the
best and expect to work in a given headache situation
and should prescribe the dose and route of administra-
tion that will provide the most rapid and complete
response to all the associated symptoms of migraine, in
addition to the pain. If the original triptan chosen is not
effective, the dose or route of administration can be
changed, the patient can be encouraged to treat attacks
earlier, another triptan can be tried or other medications,
such as NSAIDs, steroids and anti-emetics can be added
to the triptan.
There are 7 triptans tablets available in the USA as
well as 2 nasal sprays, 2 oral disintegrating tablets (ODTs)
and an injection. Their effectiveness in the early published
controlled trials is well documented. The most common
endpoint used for many years has been 2-h headache
relief; although today we also like to look at 2-h pain free-
dom, especially if the patient is instructed to take their
triptan early in the course of the migraine attack, when the
headache is often milder. Clinically, the triptans are more
similar than they are different. Dihydroergotamine is often
effective as an injection or nasal spray when available.
Other acute care treatments will be mentioned.
Cluster headache treatment will be discussed briefly.
The knowledgeable headache physician should be able
to find effective treatment for most acute headache
attacks.
General principles of acute care
– Proper treatment begins with  accurate diagnosis of all
headache types.
– A therapeutic partnership between you and the patient
is important.
– Patient education and behavioural management tech-
niques are vital.
- Teach strategies for identifying triggers of
headache.
- Urge the patient to avoid their triggers when possi-
ble.
- Strive for regular and adequate sleep, eating and
exercise routines.
- Arrange for behavioural medicine techniques
(stress management, relaxation techniques and
biofeedback).
- Prescribe psychological evaluation and therapy
when appropriate.
– Patients should be taught to participate in their own
care.
– Those looking for a magic bullet often do not do that
well.
– Patients with an inner locus of control that take over
and try to help themselves will have a better outcome.
There are various strategies to keep in mind as you evalu-
ate a patient for therapy. You need a lot of previous histo-
ry on treatment that has already occurred.
– You must review past treatments.
- What has been successful?
- If a medication did not work, was the dose correct?
- Was it given early in the attack?
- Did it cause adverse events, and what were they?
– The attack frequency determines the treatment plan.
– Think about treating the “entire” migraine complex,
not just the headache.
– Treatment needs to encompass pain relief and associ-
ated symptoms.
– Specifically ask the patient about their degree of dis-
ability.
– Consider co-morbid and co-occurring conditions and
treat them.
In your history, obtain information about co-morbid ill-
nesses that may affect headache, as these have to be treat-
ed as well. Some of the more common ones are:
– Raynaud’s disease,
– mitral valve prolapse,
– stroke at a young age,
– patent foramen ovale (PFO),
– epilepsy,
– depression,
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– anxiety/panic disorder,
– bipolar disease,
– irritable bowel syndrome.
Each patient has different expectations of a migraine med-
ication, and what one patient wants may be quite different
from another. Ideally, patients would like to get complete-
ly better quickly and get back to their usual activities,
without recurrence or adverse events. Here are the goals
we should expect from any good acute care medication:
– Treat attacks rapidly and consistently without recur-
rence eventuating in a pain-free state.
– Restore the patient’s ability to function.
– Prevent adverse events.
– Minimise the use of rescue and back-up medications.
– Optimise self-care and reduce resource utilisation.
– Be cost-effective.
How can we measure the effectiveness of our treatment?
There are many scales and endpoints that we can utilise,
such as:
– a new better goal: pain free at 2 h with no recurrence;
– severity of disability (MIDAS or HIT-6);
– duration, intensity and frequency of attacks;
– use of medical resources:
- frequency of second dosing,
- frequency of rescue medication,
- frequency of emergent care/clinic visits;
– incidence of adverse events; and
– level of patient satisfaction.
When someone comes to your office or clinic, what are
the therapeutic options that you have? I like to consider
five general categories of treatment:
– non-pharmacologic approaches (behavioural medicine
techniques),
– acute therapy (abortive, symptomatic),
– preventive therapy, on a daily basis,
– adjunctive therapies (vitamins, minerals, supplements,
herbs): vitamin B-2, magnesium, feverfew, petasites,
melatonin and coenzyme Q 10,
– physical techniques (manipulation, acupuncture, phys-
ical therapy).
Some mild headaches will not be migraine and can be
treated with non-triptans, as long as they respond. Even
some mild migraine attacks can be treated with non-trip-
tans, especially if there are frequent headaches. Here are
the types of medication that have been found to be effec-
tive in certain patients:
– OTC simple analgesics (aspirin and paracetamol),
– combination analgesics (often containing caffeine),
– non-steroidal anti-inflammatory medications (NSAIDs),
– butalbital-containing medications in the USA and a
few other countries,
– isometheptene containing combination products,
– other combination medications (usually sinus medica-
tions),
– anti-emetics,
– opiates,
– steroids,
– ergots (ergotamine tartrate and dihydroergotamine
[DHE]), and
– 5-HT agonists (triptans).
When you first see a patient with migraine, you should
choose a triptan and the best formulation for that patient.
Your choice will depend on the characteristics of a typical
attack, including intensity of pain, time to reach peak
intensity, associated symptoms such as nausea and vomit-
ing and degree of disability. You should provide a back-up
medication in case the triptan you prescribe does not
work. You should also prescribe a rescue medication in
case the back-up plan does not work.
Even before you choose a triptan, you should deter-
mine if the patient has MOH, either from OTC medication
or prescription drugs. The specific medications that are
taken in excess have changed over the last 15 years [2].
Over 60% of patients at a US tertiary care headache cen-
tre overuse acute care medications. The most common
today are triptans and a combination of acute analgesic
medications. If MOH is present, the first step is detoxifi-
cation. Not taking this into consideration may cause your
acute care medication, and even preventive therapy from
working optimally. Some facts about MOH (which we
used to call analgesic rebound headache) are that it:
– Occurs only in patients with a pre-existing, chronic
headache syndrome.
– Causes a self-sustaining rhythm of predictable and
escalating medication use.
– Causes headaches to increase in frequency and intensi-
ty and become refractory to acute care and preventive
treatments.
– Often results in escalation of headache followed by
improvement when the patient is withdrawn from the
offending medication.
Early intervention is critical in treatment with triptans.
When triptans are given, the patient should be told to take
them early in the course of the migraine attack, when the
headache is mild to moderate in intensity [3]. This usual-
ly helps them to work better. If the patient waits till the
headache progresses, and central sensitisation sets into the
brainstem, triptans are often less effective in up to 80% of
patients [4]. Early treatment means at the very start of a
migraine attack. Some patients are not sure when a
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headache starts if it will turn into a migraine attack. In that
case, I tell them to take the triptan as soon as their
headache begins to escalate. If they have only a few
migraines per month, and no mild headache, then I tell
them to medicate as soon as they develop any type of
headache. Some doctors will let patients take a triptan
tablet during a visual aura under certain conditions (the
patients always has a headache following the aura and the
aura only lasts for 20 min). In that situation, I tell patients
to use their triptan tablets 5 min into the aura. As it takes
about 30 min for the triptan to reach adequate concentra-
tions in the brain, the headache will start just before the
triptan starts to work. But do not give a nasal spray or
injection of a triptan during an aura, as it may get to the
brain too quickly, before the headache begins, and then it
may not be effective.
There are 7 triptans in the USA and most of them are
available in various countries. There are at least 3 countries
that have generic sumatriptan (Brazil, Canada and the
UK). These are the triptans and their modes of delivery:
Tablets
– sumatriptan
– zolmitriptan
– naratriptan
– rizatriptan
– almotriptan
– frovatriptan
– eletriptan
“Fast-melt” tablets or ODT
– rizatriptan-MLT
– zolmitriptan-ZMT
Suppository
– sumatriptan (Europe)
Subcutaneous injection
– sumatriptan
Nasal spray
– sumatriptan
– zolmitriptan
The pharmacokinetics of the triptans varies consider-
ably from one to another. However it has never been ade-
quately determined what pK characteristics produce the
most beneficial clinical effects. A short Tmax might pro-
duce a quicker start to efficacy or a long half-life might
increase the length of effect of a triptan, but these facts
have not been proven.
Some techniques for attaining optimal results with the
best sustained pain-free effects are:
– Use the optimal dose of triptan in the optimal formula-
tion for that patient.
– Use early intervention, and treat when the pain is mild,
no more than 30 min into a migraine attack.
– Add an NSAID to the triptan to improve efficacy and
decrease recurrence.
– Set limits on the number of days per week, on average,
that your patients use triptans or any other acute care
medication. My upper limit is an average of 2
days/week for acute care medications. That will not
usually cause MOH or increase the frequency of
attacks.
After choosing a triptan, have the patient treat at least
two or three attacks before judging its effectiveness.
Review outcome measures with the patient to see if the
triptan is working properly. Having the patient keep a
diary or calendar is essential to getting accurate reporting
from the patient. You should assess efficacy, adverse
events, speed of onset, completeness of response, recur-
rence and patient satisfaction with the current regimen, to
determine if the triptan is working optimally or needs to
be changed. Each patient may prefer their own goals for
improvement, some wanting quick relief and others want-
ed long-lasting relief or no adverse events [5]. If the treat-
ment is not working, consider:
– choice of drug,
– choice of dose or route of administration,
– need for adjunct therapy,
– presence of interfering medication or medication
overuse, and
– incorrect diagnosis.
The range of efficacy of the triptans is wide. Although
some consistently seem to work better than others in head
to head studies, there is probably one triptan that is best for
each patient. The only way to tell if the triptan a patient is
using is optimal is to ask questions about how it works
when the patient comes in to the office. Typical questions
are: In how many minutes does the triptan start to work?
When does it reach its maximum effect? What percentage
of the headache goes away? Does the headache recur after
it is gone? Are there any significant adverse events? If the
answers do not indicate optimal efficacy with few adverse
events, then another triptan should be tried.
Cluster headache often responds well to specific acute
care medications such as:
– 100% oxygen inhalation at 7–10 l/min (up to 15 l/min
if refractory);
– sumatriptan 6 mg sc at headache onset;
– zolmitriptan 10 mg tablet or 5 mg nasal spray;
– DHE 0.5–1.0 mg by injection or 2 mg by nasal spray;
– ergotamine tartrate orally or rectally;
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– lidocaine 4–6% nasal drops at headache onset;
– intranasal capsaicin or the z isomer civamide.
In conclusion, the acute care of migraine and cluster
headache can be very effective and patients are often able
to control their headaches when they occur. Here are some
concluding suggestions to help your patients achieve opti-
mal therapy:
– Triptans should be your first acute care choice for dis-
abling migraine attacks, in the absence of vascular and
other contraindications.
– Treat MOH first, before using triptans.
– Use a stratified care approach, and give the right treat-
ment the first time.
– Set limits on acute care medications. I suggest only 2
days/week.
– Administer triptans early in the attack, when pain is
mild, in an optimal formulation to maximise likelihood
of a sustained, pain-free response.
– Change triptan or route of administration if response is
poor.
– The addition of an NSAID, such as naproxen sodium,
to the triptan at initial presentation, both increases effi-
cacy and reduces recurrence, making a sustained pain-
free response even more likely.
– Triptans are more similar than different, but there may
be one triptan or formulation of that triptan which is
the best for each patient.
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